Akèy › Limfom Selil-T › Texas › Houston
Etid klinik pou Limfom Selil-T nan Houston, TX
8 etid pou Limfom Selil-T ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Ap rekriteEtid obsèvasyon
- Texas Children's Hospital, Houston
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Ap rekriteFaz 3
- MD Anderson Cancer Center, Houston
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
Ap rekriteFaz 1
- The University of Texas M. D. Anderson Cancer Center, Houston
CD4CAR for CD4+ Leukemia and Lymphoma
Ap rekriteFaz 1
- The University of Texas MD Anderson Cancer Center, Houston
A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
- MD Anderson Cancer Center (Data Collection Only), Houston
MB-105 in Patients With CD5 Positive T-cell Lymphoma
Ap rekriteFaz 2
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- The University of Texas MD Anderson Cancer Center, Houston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Ap rekriteFaz 1
- Texas Children's Hospital/Baylor College of Medicine, Houston
Etid Limfom Selil-T nan lòt vil
- New York City, NY13 etid
- Philadelphia, PA10 etid
- Baldwin Park, CA9 etid
- Boston, MA9 etid
- Atlanta, GA8 etid
- Chicago, IL6 etid
- Seattle, WA6 etid
- Columbus, OH6 etid
- Rochester, MN6 etid
- New Haven, CT5 etid
- Miami, FL5 etid
- Ann Arbor, MI4 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.